S. Allard

发表

Therapeutic Vaccine in Chronically HIV-1-Infected Patients: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Trial with HTI-TriMix †

J. Martinez-Picado, C. Brander, Felipe García, 2019, Vaccines.

Heparin-binding, hemagglutinin-specific IFN-gamma synthesis at the site of infection during active tuberculosis in humans.

C. Locht, F. Mascart, T. M. Doherty, 2010, American journal of respiratory and critical care medicine.

SARS-CoV-2 RNA and antibodies in tear fluid

M. Bjerke, R. Kuijpers, I. Wybo, 2021, BMJ Open Ophthalmology.

Immuno-Diagnosis of Active Tuberculosis by a Combination of Cytokines/Chemokines Induced by Two Stage-Specific Mycobacterial Antigens: A Pilot Study in a Low TB Incidence Country

C. Locht, F. Mascart, J. Racapé, 2022, Frontiers in Immunology.

Diagnostic accuracy of screening tests for patients suspected of COVID-19, a retrospective cohort study

B. Ilsen, D. Piérard, S. Allard, 2021, Infectious diseases.

The relation between ACEI/ARB use and COVID-19 severity in RT-PCR–confirmed cases: A retrospective case-control study

J. Mey, N. Buls, S. Allard, 2020, Cardiology and Cardiovascular Medicine.

iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy

À. Olvera, J. Martinez-Picado, C. Brander, 2019, Trials.

Blood tolerogenic monocytes and low proportions of dendritic cell subpopulations are hallmarks of human tuberculosis

T. Giese, F. Mascart, M. Hites, 2018, Journal of leukocyte biology.

Early treatment with inhaled GM-CSF improves oxygenation and anti-viral immunity in COVID-19 induced lung injury – a randomized clinical trial

A. Sette, S. Dupont, R. Seurinck, 2021 .

The role of cardiovascular imaging for myocardial injury in hospitalized COVID-19 patients

Johan de Mey, Steffen E Petersen, Thor Edvardsen, 2020, European heart journal cardiovascular Imaging.

Expansion of Polyfunctional HIV-Specific T Cells upon Stimulation with mRNA Electroporated Dendritic Cells in the Presence of Immunomodulatory Drugs

J. Aerts, P. Lacor, R. Schots, 2012, Journal of Virology.

Presence of Immunomodulatory Drugs Electroporated Dendritic Cells in the Cells upon Stimulation with mRNA Expansion of Polyfunctional HIV-Specific T

J. Aerts, P. Lacor, R. Schots, 2012 .

Expansion of polyfunctional HIV-specific T cells upon stimulation with 1 mRNA electroporated dendritic cells in the presence of 2 immunomodulatory drugs 3 4 Short title : Effects of IMiDs on HIV-specific T cells 5 6 7

J. Aerts, P. Lacor, R. Schots, 2012 .

High uptake of pre-exposure prophylaxis (PrEP) during early roll-out in Belgium: results from surveillance reports.

B. Vuylsteke, M. Laga, C. Nöstlinger, 2019, Sexual health.

Efficient Induction of Antigen-Specific CD8+ T-Cell Responses by Cationic Peptide-Based mRNA Nanoparticles

G. Vanham, J. Aerts, Sigrid D'haese, 2022, Pharmaceutics.

Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment

A. Sette, S. Dupont, R. Seurinck, 2022, Cell Reports Medicine.

Healthcare-Associated COVID-19 across Five Pandemic Waves: Prediction Models and Genomic Analyses

T. Seyler, I. Wybo, O. Soetens, 2022, Viruses.

Beyond Guidelines and Reports on Bacterial Co-/Superinfections in the Context of COVID-19: Why Uniformity Matters

D. Piérard, S. Allard, J. Van Laethem, 2022, Antibiotics.

Nevirapine-induced toxic epidermal necrolysis and toxic hepatitis treated successfully with a combination of intravenous immunoglobulins and N-acetylcysteine.

P. Lacor, A. de Coninck, S. Allard, 2004, European journal of internal medicine.

A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption.

P. Eilers, A. Osterhaus, J. Aerts, 2012, Clinical immunology.

Current challenges in the treatment of HIV.

P. Lacor, L. Seyler, S. Allard, 2018, Polish archives of internal medicine.

Belgian guidelines for non-occupational HIV post-exposure prophylaxis 2017

J. Yombi, S. De Wit, I. Derdelinckx, 2018, Acta clinica Belgica.

Efficient stimulation of HIV-1-specific T cells using dendritic cells electroporated with mRNA encoding autologous HIV-1 Gag and Env proteins.

Bernard Verrier, Concepción Marañón, Peter Ponsaerts, 2006, Blood.

Sequence evolution and escape from specific immune pressure of an HIV-1 Rev epitope with extensive sequence similarity to human nucleolar protein 6.

J. Aerts, P. Lacor, C. Heirman, 2012, Tissue antigens.

The combination of 4‐1BBL and CD40L strongly enhances the capacity of dendritic cells to stimulate HIV‐specific T cell responses

J. Aerts, P. Lacor, C. Heirman, 2011, Journal of leukocyte biology.

HIV-1 evolution in patients undergoing immunotherapy with Tat, Rev, and Nef expressing dendritic cells followed by treatment interruption

P. Lemey, A. Osterhaus, J. Aerts, 2013, AIDS.

Fear for CoViD-19 and reluctance to work among health care workers during the epidemic, a prospective monocentric cohort study

D. Piérard, S. Allard, S. Van Laere, 2021, American Journal of Infection Control.

Rapid viral rebound after analytical treatment interruption in patients with very small HIV reservoir and minimal on‐going viral transcription

G. Vanham, J. Aerts, L. Vandekerckhove, 2020, Journal of the International AIDS Society.

Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial

Inge Christoffer Olsen, F. Lund-Johansen, Mariana H. S. Bernardo, 2023, Critical Care.

Autologous dendritic cell vaccination against HIV-1 induces changes in natural killer cell phenotype and functionality

J. Aerts, Sigrid D'haese, R. Gruters, 2023, npj Vaccines.

Surfing the Waves: Differences in Hospitalised COVID-19 Patients across 4 Variant Waves in a Belgian University Hospital

D. De Cock, L. Seyler, S. Allard, 2023, Viruses.

Efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide for the treatment of HIV in a real‐world setting in Belgium

P. Messiaen, J. Yombi, L. Vandekerckhove, 2023, HIV medicine.

Lumenal part of the DC-LAMP protein is not required for induction of antigen-specific T cell responses by means of antigen-DC-LAMP messenger RNA-electroporated dendritic cells.

J. Aerts, C. Heirman, K. Thielemans, 2010, Human gene therapy.

Functional T-cell responses generated by dendritic cells expressing the early HIV-1 proteins Tat, Rev and Nef.

A. Osterhaus, J. Aerts, P. Lacor, 2008, Vaccine.

Qualitative plasma viral load determination as a tool for screening of viral reservoir size in PWH

G. Vanham, J. Aerts, L. Vandekerckhove, 2022, AIDS.

Corrigendum to ‘A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption’ [Clin. Immunol. 142 (2012) 252–268]

P. Eilers, A. Osterhaus, J. Aerts, 2014 .

Presumed Urinary Tract Infection in Patients Admitted with COVID-19: Are We Treating Too Much?

P. Lacor, D. Piérard, L. Seyler, 2021, Antibiotics.

Clinical features of Legionnaires’ disease at three Belgian university hospitals, a retrospective study

P. Clevenbergh, E. Balti, N. Dauby, 2021, Acta clinica Belgica.

Using risk factors and markers to predict bacterial respiratory co-/superinfections in COVID-19 patients: is the antibiotic steward’s toolbox full or empty?

N. Dauby, S. Allard, J. Van Laethem, 2023, Acta clinica Belgica.

Antibiotic Prescriptions Targeting Bacterial Respiratory Infections in Admitted Patients with COVID-19: A Prospective Observational Study

B. Ilsen, P. Lacor, D. Piérard, 2021, Infectious Diseases and Therapy.

Efficacy, durability, and tolerability of dolutegravir/lamivudine and dolutegravir/rilpivirine for the treatment of HIV in a real‐world setting in Belgium

P. Messiaen, J. Yombi, S. De Wit, 2022, HIV medicine.

Re: predictors and microbiology of respiratory and bloodstream infection in patients with COVID-19

S. Allard, J. Van Laethem, 2022, Clinical Microbiology and Infection.

Healthcare-associated COVID-19 across 3 pandemic waves: patient characterisation and validation of clinical definitions using genome sequencing

T. Seyler, I. Wybo, O. Soetens, 2022 .